Clinical Trials & Research

An Update on the Circulating Tumor Cell Biomarker Panel (CTC) as Surrogate for Survival in Prostate Cancer

We are in desperate need of validated biomarkers, which can serve as surrogates for survival. Currently, our doctors must make decisions about which drugs to use and how long to stay on these drugs without any scientific backup or consensus driven direction to their decisions. Our clinical trials for evaluating survival of potential new advanced [...]

By |2020-02-04T10:39:25-05:00April 30th, 2015|Advanced Prostate Cancer, biomarkers, Biomarkers and Prognostic Tools, Clinical Trials & Research, CTCs, prognostic tools, Uncategorized|0 Comments
Read More

Funding Time for the DOD Prostate Cancer Research Program – Help Us To Protect It

Malecare has been an active and early member of the Defense Health Research Consortium. The consortium currently consists of 47 different organizations, which educate and advocate for research Department of Defense funding for multiple different diseases and syndromes. The consortium’s goal is to lobby Congress to continue to and to expand support for the Department [...]

By |2017-10-19T10:47:24-04:00April 15th, 2015|Advanced Prostate Cancer, Advocacy, Agent Orange, Clinical Trials & Research, General Information, Politics of Cancer, Research, Uncategorized|0 Comments
Read More
Go to Top